Search results

Accelerator Mass Spectrometry (AMS) is an ultra-sensitive analytical technique based on the use of an ion accelerator as a powerful mass spectrometer.

Seven of Australia’s top nuclear medicine professionals have been briefed on ANSTO’s plans to manage radioactive waste, as well as to support nuclear medicine innovation in Australia.

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

Three new federal grants were announced to support manufacturing and nuclear technologies.

ANSTO’s Lucas Heights campus has an extensive range of specialised facilities and capabilities that are available to assist industry-based professionals in solving problems. Please contact us to discuss how we can assist you. We are open to entering into commercial arrangement with appropriate partners.

The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.

Frequently asked questions about beamtime, accommodation and the user portal.

New facility will greatly enhance Australia’s capability in stress engineering for industry

Health researchers at ANSTO use world-class nuclear and isotopic techniques to undertake research and development activities to address some of the most challenging health problems.

Strategic partnership with the University of Sydney expanded to continue a long history of research collaboration.

A new source added to ANSTO’s cosmogenic toolkit to study past climate and landscape change

Invisible deuterated detergents revealed

Report to the independent nuclear regulator, ARPANSA, and the IAEA